iBio (IBIO) Accumulated Depreciation (2018 - 2026)

iBio (IBIO) has 9 years of Accumulated Depreciation data on file, last reported at $1.9 million in Q1 2026.

• On a quarterly basis, Accumulated Depreciation rose 38.79% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 38.79% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 47.87% from the prior year.
• Accumulated Depreciation for Q1 2026 stood at $1.9 million, up from $1.8 million in the prior quarter.
• Over the last five years, Accumulated Depreciation for IBIO reached as high as $1.9 million in Q1 2026 and fell as low as $115000.0 in Q4 2022.
• Historically, Accumulated Depreciation has averaged $1.0 million across 5 years, with a median of $1.1 million in 2024.
• Across the five-year window, Accumulated Depreciation soared 533.91% in 2023 and surged 38.79% in 2026, its largest moves.
• Year by year, Accumulated Depreciation stood at $115000.0 in 2022, then surged by 533.91% to $729000.0 in 2023, then soared by 71.88% to $1.3 million in 2024, then soared by 40.38% to $1.8 million in 2025, then grew by 8.41% to $1.9 million in 2026.
• Per Business Quant data, the three most recent Accumulated Depreciation figures were $1.9 million in Q1 2026, $1.8 million in Q4 2025, and $1.6 million in Q3 2025.